The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges

Prostate cancer (PCa) is the most common cause of malignancy in males and the second leading cause of cancer mortality in United States. Current treatments for PCa include surgery, radiotherapy, and androgen-deprivation therapy. Eventually, PCa relapses to an advanced castration-resistant PCa (CRPC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Eun-Jin, Lo, U-Ging, Hsieh, Jer-Tsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730868/
https://www.ncbi.nlm.nih.gov/pubmed/29264188
http://dx.doi.org/10.1016/j.ajur.2016.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730868/
https://www.ncbi.nlm.nih.gov/pubmed/29264188
http://dx.doi.org/10.1016/j.ajur.2016.09.006

Ejemplares similares